The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 14, 2014
Filed:
Nov. 01, 2010
Applicant:
Shaker A. Mousa, Wynantskill, NY (US);
Inventor:
Shaker A. Mousa, Wynantskill, NY (US);
Assignee:
Vascular Vision Pharmaceutical Company, Rensselaer, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/554 (2006.01); A61K 31/4406 (2006.01); A61K 31/27 (2006.01); C07C 271/22 (2006.01); C07C 279/08 (2006.01); A61K 31/54 (2006.01); A61K 31/195 (2006.01); C07C 275/24 (2006.01); C07D 295/155 (2006.01); A61K 31/24 (2006.01); C07C 271/16 (2006.01); C07C 217/20 (2006.01); C07D 213/36 (2006.01); C07C 239/12 (2006.01);
U.S. Cl.
CPC ...
A61K 31/195 (2013.01); C07C 279/08 (2013.01); A61K 31/54 (2013.01); C07C 275/24 (2013.01); C07D 295/155 (2013.01); A61K 31/24 (2013.01); C07C 271/16 (2013.01); A61K 31/27 (2013.01); C07C 217/20 (2013.01); C07D 213/36 (2013.01); A61K 31/4406 (2013.01); C07C 239/12 (2013.01);
Abstract
A dual thyrointegrin antagonist and a method for treating an angiogenesis-mediated disorder and/or a hyperthyroidism disorders by introducing the dual thyrointegrin antagonist into animals (e.g., mammals, human beings). The dual thyrointegrin antagonist includes a chemical structure having a thyroid hormone antagonist and αvβintegrin antagonist in the same molecule.